SELLAS Life Sciences Group (SLS) Earnings Date & Reports

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SLS is expected to report earnings to rise 40.00% to -7 cents per share on August 06

SELLAS Life Sciences Group SLS Stock Earnings Reports

Q2'26

Est.

$-0.07

Q1'26

Beat

by $0.02

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.02

Q2'25

Beat

by $0.01

The last earnings report on May 12 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 8.10M shares outstanding, the current market capitalization sits at 1.68B.

View a ticker or compare two or three

Compare

SLS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for SLS